Jeffrey C. Leer - 18 Mar 2023 Form 4 Insider Report for AlerisLife Inc.

Reporting relationship: PRESIDENT AND CEO
Issuer ticker: N/A
Reported as of: 18 Mar 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Mar 2023, 09:14:26 UTC
Prior SEC filing: 20 Dec 2022
Next SEC filing: 02 Oct 2024
Source filing: View source filing
Reporting owner signature: /s/ Jeffrey C. Leer

Key filing fact

Jeffrey C. Leer filed Form 4 for AlerisLife Inc. on 20 Mar 2023.

Key facts

This page summarizes Jeffrey C. Leer's Form 4 filing for AlerisLife Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 20 Mar 2023, 09:14.

Change

Previous filing in this sequence was filed on 20 Dec 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALR transaction

Common Stock

Disposition pursuant to a tender of shares in a change of control transaction

Transaction value
Shares: -433,363
Change %: -100%
Price
Shares after: 0
Date: 18 Mar 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Jeffrey C. Leer is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of February 2, 2023, by and among the Issuer, ABP Acquisition LLC ("Parent"), and ABP Acquisition 2 LLC, a direct wholly owned subsidiary of Parent ("Purchaser"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer effective as of March 20, 2023 (the "Effective Time"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $1.31 in cash without interest and subject to applicable withholding taxes.